Abstract
We evaluated the mechanisms of histamine-mediated adenylate cyclase stimulation in 18 human hearts obtained from cardiac transplant recipients or prospective donors. Mg2+ and guanyl nucleotide were required for histamine stimulation. In the presence of 10-5 M GTP, histamine produced a maximal stimulation of 1.54 +/- 0.06 times basal activity in left ventricle (39% of the isoproterenol maximum), which rose to 1.75 +/- 0.14 times basal activity (68% of the isoproterenol maximum) in the presence of a 10-5M concentration of the synthetic guanyl nucleotide 5'-guanylyl imidodiphosphate. Histamine stimulation of adenylate cyclase was antagonized by cimetidine (KB = 1.58 X 10-6 M) but not by H1-blocking doses of mepyramine or pyrrobutamine. The selective H2 agonist dimaprit stimulated adenylate cyclase to approximately the same extent as histamine, whereas a selective H1 agonist produced only minimal stimulation that was H2-mediated. The selective H2 agonist impromidine was a partial agonist and produced approximately 20-40% of maximal histamine stimulation at lower concentrations (10-7 and 10-6 M) and inhibition of histamine stimulation at higher concentrations (10-5 and 10-4 M). Histamine stimulated adenylate cyclase activity over the same dose range as that which produced a positive inotropic response in isolated papillary muscles. Under one set of assay conditions, contractile response and adenylate cyclase does-response curves were essentially super-imposable. We conclude that human myocardial adenylate cyclase is coupled to the H2 receptor and linked to the contractile response, whereas the H1 receptor does not mediate a biochemical or mechanical effect.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|